Dr. Reddy’s Laboratories has received the Establishment Inspection Report (EIR) from the US Food & Drug Administration (USFDA) for its Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad as closure of audit.
Earlier in April, USFDA had inspected the Formulations Manufacturing Plant - 3 wherein it had issued a form 483 with 11 observations.
Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
